Related Experiment Video
Updated: Oct 3, 2025
09:25
Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
11.5K
Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
Alison Cheung1, Sidrah Shah2, Jack Parker1
1Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Kent ME7 5NY, UK.
International Journal of Environmental Research and Public Health
|February 15, 2022
Summary
This review updates knowledge on rare non-epithelial ovarian cancers (NEOC), including germ cell tumours (GCT) and sex cord-stromal tumours (SCST). It covers their presentation, pathology, genetics, treatment, and survival, aiding further research.
Area of Science:
- Gynecologic Oncology
- Rare Cancers
- Molecular Pathology
Background:
- Non-epithelial ovarian cancers (NEOC) are rare malignancies comprising germ cell tumours (GCT), sex cord-stromal tumours (SCST), and other rare types.
- Existing knowledge on NEOC etiology, molecular origins, and genetic alterations requires further investigation and optimization.
Purpose of the Study:
- To provide a comprehensive update on the clinical presentation, pathology, genetics, treatment, and survival of major NEOC subtypes.
- To discuss miRNA expression profiles in NEOC.
- To report ongoing clinical trials for NEOC.
Main Methods:
- Literature review and synthesis of current data on NEOC subtypes.
- Analysis of clinical presentation, histopathology, and genetic findings.
- Review of treatment strategies and survival outcomes.
Main Results:
- Detailed overview of GCT, SCST, and small cell carcinoma subtypes.
- Discussion of specific genetic alterations and miRNA expression patterns.
- Summary of current treatment modalities and survival statistics.
Conclusions:
- Further research into the etiology and molecular basis of NEOC is crucial.
- Optimizing understanding of genetic changes is needed for improved management.
- This review consolidates current knowledge and highlights areas for future investigation and clinical trials.
